NYSE - Delayed Quote USD

Hims & Hers Health, Inc. (HIMS)

Compare
17.13 -1.82 (-9.60%)
At close: 4:00 PM EDT
17.20 +0.07 (+0.41%)
After hours: 5:41 PM EDT
Loading Chart for HIMS
DELL
  • Previous Close 18.95
  • Open 16.95
  • Bid 17.07 x 1300
  • Ask 17.06 x 900
  • Day's Range 16.05 - 17.39
  • 52 Week Range 5.65 - 25.74
  • Volume 24,835,568
  • Avg. Volume 8,141,271
  • Market Cap (intraday) 3.708B
  • Beta (5Y Monthly) 1.06
  • PE Ratio (TTM) 214.12
  • EPS (TTM) 0.08
  • Earnings Date Nov 4, 2024 - Nov 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 21.93

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

www.forhims.com

1,046

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HIMS

View More

Related Videos: HIMS

Performance Overview: HIMS

Trailing total returns as of 10/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HIMS
92.47%
S&P 500
19.50%

1-Year Return

HIMS
165.58%
S&P 500
32.92%

3-Year Return

HIMS
134.66%
S&P 500
30.82%

5-Year Return

HIMS
73.56%
S&P 500
97.39%

Compare To: HIMS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HIMS

View More

Valuation Measures

Annual
As of 10/2/2024
  • Market Cap

    4.10B

  • Enterprise Value

    3.89B

  • Trailing P/E

    236.88

  • Forward P/E

    45.05

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.94

  • Price/Book (mrq)

    11.33

  • Enterprise Value/Revenue

    3.64

  • Enterprise Value/EBITDA

    164.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.70%

  • Return on Assets (ttm)

    2.17%

  • Return on Equity (ttm)

    5.31%

  • Revenue (ttm)

    1.07B

  • Net Income Avi to Common (ttm)

    18.1M

  • Diluted EPS (ttm)

    0.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    227.29M

  • Total Debt/Equity (mrq)

    3.17%

  • Levered Free Cash Flow (ttm)

    82.37M

Research Analysis: HIMS

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 315.65M
Earnings 13.3M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

16.00
21.93 Average
17.13 Current
30.00 High
 

Company Insights: HIMS

People Also Watch